Biosafety and Bioethics Dr. Sarah bukhari Ass.Prof. pharmaceutical microbiology.

Slides:



Advertisements
Similar presentations
Contents Part 1: What is the Protocol on Biosafety? Part 2:
Advertisements

Cartagena Protocol on Biosafety -Reducing the Environmental Risks of Modern Biotechnology Secretariat of the Convention on Biological Diversity
Erie Tamale Secretariat of the Convention on Biological Diversity
THE NIH RECOMBINANT DNA 2002 GUIDELINES East Carolina University September 5, 2007.
Biological Laboratory Safety Additional Information.
Ethical regulations for health research involving human subjects in Cambodia By Chap Seak Chhay, MD, MPH, MHPEd Public Health and Health Professions Educator.
BIOLOGICAL HAZARDS RISK ASSESSMENT
Ethics in HealthCare. Treating Patients With Dignity Sometimes health professionals get so wrapped up in the scientific principles of healthcare that.
The principles In Medical Ethics Lecturer :Noha Alaggad
The International Regulation of Biotechnology Lecture No. 19 Further Inf. For further information and video link please click on the right buttons in the.
Principles and Practices of Biosafety Environmental Health and Safety San Diego State University.
The International Regulation of Biotechnology Lecture No. 19.
BIOSAFETY IN HEALTH RESEARCH Annah R. Takombwa – Acting Technical Affairs Manager, National Biotechnology Authority.
Laboratory Management - 1
1 THE BIOTECHNOLOGY POLICY AND BIOSAFETY MECHANISMS FOR GMOs IN KENYA George M. Siboe, School of Biological Sciences University of Nairobi.
Issues and Ethics in Biotechnology. ETHICS Set of moral principles governing an individual’s action Reflects morality (perception of what is right) Essential.
Biotechnology Heather Pereira. What is Biotechnology?  Biotechnology is defined by the US government as any technique that uses living organisms (or.
Biosecurity Laws and Regulations in Turkey Prof. Dr. Hüseyin Avni Öktem Nanobiotechnology R&D Group, Department of Biological Sciences Middle East Technical.
GMOs and the WTO Rules Mark Halle Minsk, 24 October 2008.
“PRECAUTION AND THE REGULATION OF LIVING MODIFIED ORGANISMS (LMOs)” EMMA ISSATT.
Cartagena Protocol on Biosafety Drew L. Kershen University of Oklahoma College of Law Earl Sneed Centennial Professor of Law Copyright 2005, all rights.
Regulatory Authority Governing Clinical Trials Anthony J. Minisi, MD Director, Cardiology Fellowship Program.
Local Recombinant DNA Oversight Mass Biotech Council Series Enforcement of the Cambridge Recombinant DNA Technology Ordinance Cambridge Biosafety Committee.
Confronting Contamination: Biosafety Lim Li Lin, Third World Network.
Training Workshop for Regional Advisors Bangkok, Thailand 15 – 27 May 2006.
Overview of the EU Food Safety Requirements
Potential trade implications of CBD and the Cartagena Protocol on Biosafety MEA – UNEP meeting on Enhancing MEA and WTO Information Exchange 11 November,
Discuss the major characteristics of the four Biosafety Levels. Define “Risk Group” and give an example of each. Discuss how Risk Groups are used in conjunction.
Safety organization and training. The biosafety officer and biosafety committee A safety policy, A safety manual, and Supporting programmes for their.
An Introduction to CPB and Importance of BCH to CPB Obligations.
Creating a Conducive Environment for Biotechnology: The Cartagena Protocol as an Enabling Framework Drew L. Kershen Earl Sneed Centennial Professor University.
The New Science of Food: Facing Up to Our Biotechnology Choices Prepared by Mark Edelman, Iowa State University David Patton, Ohio State University A Farm.
LEGAL / ETHICAL / SOCIAL ISSUES
Research Ethics & Compliance Dr Simon Barrett Manager, Research Ethics & Compliance Monash Research Office.
Ethics in pharmacy practice
1 Proposal To Extend the Application of the Convention on Biological Diversity and the Biosafety Protocol to the Hong Kong SAR.
Genetic Engineering Chapter 15. Selective Breeding Allowing only animals with wanted characteristics to breed.
Reclaimed Wastewater Quality Criteria, Standards, and Guidelines
Biotechnology: Monster or Miracle?
Issues and Ethics in Biotechnology
Guatemala: An evaluation of Biosafety Regulations Drew L. Kershen Earl Sneed Centennial Professor Univ. of Oklahoma, College of Law Copyright 2007, all.
Cartagena Protocol on Biosafety Cartagena Protocol on Biosafety And India’s Obligations By Desh Deepak Verma Joint Secretary, Ministry of Environment and.
Biotechnology Technology is essential to science for such purposes as sample collection and treatment, measurement, data collection and storage, computation,
LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER NEW ORLEANS.
Understanding Animal Welfare Issues. Next Generation Science/Common Core Standards Addressed! RST.9 ‐ 10.8 Assess the extent to which the reasoning and.
ETHICAL ISSUES AND INFORMED CONSENT Juan M. Lozano, MD, MSc Department of Paediatrics and Clinical Epidemiology Unit School of Medicine, Javeriana University.
1 DEAT PERSPECTIVE ON GENETICALLY MODIFIED ORGANISMS 31 JULY 2007.
Unit B Animal Science and The Industry. Problem Area 6 Meeting Environmental Requirements of Animals.
Objectives  Define risk assessment as it relates to biosafety  Understand the risk assessment process and how to implement it  Discuss risk factors.
NIH Guidelines for Research Involving rDNA Molecules (NIH Guidelines) and Institutional Biosafety Committees.
Ethics in Research Each research study involves a careful risk/benefit analysis prior to beginning data collection. The question each researcher must ask.
State Standards Biotechnology. Understand how biotechnology is used to affect living organisms. Summarize aspects of biotechnology including: Specific.
Biotechnology North Carolina. Biotechnology Terms.
National Food Control Systems
….Is GE inherently unsafe?
Genetic modification.
ROLE OF THE INSTITUTIONAL BIOSAFETY COMMITTEE
THE ETHICAL ISSUES THAT ARISE FROM THE PRODUCTION OF GMOs
ICH-GCP Avinash Kondawar M. Pharm Lead CRA
Ethics in pharmacy practice
Environmental and Biosafety issues in modern Biotechnology
Working with Biological Hazards
Biotechnology.
Biotechnology Notes 8.L.2.1.
Lecture 9: PHC As a Strategy For HP Dr J. Sitali
Biotechnology with a conscience
بنام خداوند جان و خرد كزين برتر انديشه بر نگذرد
Contents Part 1: What is the Protocol on Biosafety? Part 2:
Cartagena Protocol on Biosafety -Reducing the Environmental Risks of Modern Biotechnology Secretariat of the Convention on Biological Diversity
Ethics of the Use of Animals in Scientific Research: Legislation
Presentation transcript:

Biosafety and Bioethics Dr. Sarah bukhari Ass.Prof. pharmaceutical microbiology

Ancient Greek Chimera The Chimera was a hybrid monster of ancient Greek legend that was thought to live in southwest Anatolia (present-day Turkey).

OUTLINE New limits to the interference with life? How do we know what is acceptable? What are the concerns of the public? What will be considered ethically acceptable?

NEW LIMITS TO THE INTERFERENCE WITH LIFE?

NEW LIMITS TO THE INTERFERENCE WITH LIFE? (1/2) During the last century scientists have made genuine progress in explaining and usefully modifying the processes of life Until recently, the main limits to interference with life were of a technical kind: what is possible to do? Increasingly scientists and industry are faced with ethical limits: what is acceptable to do?

NEW LIMITS TO THE INTERFERENCE WITH LIFE? (2/2) Breeding has changed domestic animals over thousands of years However, genetic changes were poorly understood until recently Modern genetics, scientific breeding schemes and others forms of biotechnology have increased our control With greater control comes greater responsibility

HOW DO WE KNOW WHAT IS ETHICALLY ACCEPTABLE?

Basic ethical principles Major Ethical Principles. secondary Ethical Principles.

Major Ethical Principles Non-maleficence Beneficence Autonomy Justice

Secondary Ethical Principles truth tellingfidelity and promise keepingconfidentialityhow much harm can be justifiably risked to effect goodAttempt to avoid undesirable exceptions

Medical ethics Medical ethics is the study of moral values and judgments as they apply to medicine.

Medical issues ABORTION Vaccine controversy Cloning Gene therapy

WHAT ARE THE CONCERNS OF THE PUBLIC?

EUROPEAN ATTITUDES TO BIOTECHNOLOGY Since 1991 the Eurobarometer surveys have examined the attitudes of the European public In general the surveys show that members of the European public Differentiate between medical and agricultural applications Do not become more positive towards biotechnology the more they know about it Are most sceptical towards biotechnology when it is applied to animals or food-production

SHOULD BIOTECHNOLOGY BE ENCOURAGED? Eurobarometer 1996: Mean score in the EU Range from - 2 to + 2

WHAT WILL BE CONSIDERED ETHICALLY ACCEPTABLE?

THREE GROUPS OF CONCERNS Concern for animals –Animal welfare –Animal integrity Concern for environment/nature –Biodiversity Concerns for humans –Biosafety –Slippery slope concerns –Need for ”nature”

FEATHERLESS CHICKEN

BLIND HENS

BRINGING IN SCIENTIFIC UNCERTAINTY Some of the consequences for animal welfare of biotechnology can be foreseen However, many consequences are unforeseen; and researchers clearly tend to be much too optimistic A good example is cloning

WHAT WILL BE CONSIDERED ETHICALLY ACCEPTABLE? The debate must allow all concerns to be heard and discussed Given the widely shared sceptical views presented in this talk it will only be considered acceptable to use biotechnology if important benefits are at stake

What can we do with rDNA? “Pharming”: modify organisms to produce drugs or other usable materials (also xeno-technology) Research: designing model organisms GM agriculture: modify crops or animals for human consumption Gene therapy: modify genetic disease “Designer babies”: modify offspring Bio-weapons: modify biological agents

What can we do with rDNA?

‘Biosafety’ means the need to protect human and animal health and environment from the possible adverse effects of the products of modern biotechnology BIOSAFETY BIOSAFETY

The Cartagena Protocol on Biosafety (CPB) Entered into force on 29 th December 1993 Seeks to lay down an internationally acceptable framework to provide for an adequate level of protection against the possible adverse effects on biodiversity and human health.

Basic Premises of CPB “Advance Informed Agreement” between Parties (AIA) Decision on the basis of scientific risk assessment Precautionary Principle

Lab safety Lab safety: Each laboratory should adopt Standard operational procedures from guidelines of the WHO according to the type of work being carried out in their lab by: identifying potential hazards, and specifies practices and procedures to eliminate or minimize such hazards. Such operational procedures should be logged and made available in form of Laboratory manual to protect workers, products, co-workers, lab support personnel and environment.

Safety practices should be applied throughout the testing process and this met by three main steps: Pre- analytical Analytical Post- analytical

1. Pre- Analytical which include Specimen collection, Specimen preparation and Specimen transport. The accuracy of test results depends greatly on the quality of the specimen. Therefore, proper specimen collection, preparation and handling is essential for samples submitted to the laboratory for testing.

2. Analytical which include testing: follow the safety rules when performing any test in the lab.

3. Post- Analytical disposal: After testing, clean up working area and properly dispose of contaminated waste.

Also known as BMBL 5—Describes the Centers for Disease Control and Prevention/National Institutes of Health (CDC/NIH) guidelines for each BSL Appropriate work for each BSL is described with combinations of the following : Laboratory Practices and Techniques Standard Practices Special Practices Safety Equipment (Primary Barriers) Laboratory Facilities (Secondary Barriers) Biosafety in the Microbiology and Biomedical Laboratory

Thank you